The United States Trade Representative has formally told the European Union that it is interested in continuing an effort aimed at ensuring a normalization of biotechnology trade in the wake of a ruling by the World Trade Organization that the EU’s approval process for genetically modified organisms has run afoul of the procedures that guide sanitary and phytosanitary measures, and that member state bans on products previously approved in the EU violate the WTO.